Site icon pharmaceutical daily

Rebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP (“NYMX-Q”)

CARSON CITY, Nev. & LONDON–(BUSINESS WIRE)–AscellaHealth:

WHO: Newly formed organization, The Committee to Restore Nymox Shareholder Value, Calls for Shareholder Support

WHAT: Following the distribution of a press release by Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business on July 7, 2023, rebuttal letters are being issued to all Company shareholders. Access the documents at www.crnsv.com

When: July 10, 2023

Where: CARSON CITY, Nevada; LONDON

Why: Summary of Rebuttal Letters:

 

Contacts

Chris Riley

info@crnsv.com

Exit mobile version